Silence Therapeutics PLC (SLN) — Long-term Investment Intensity
Silence Therapeutics PLC (SLN) has a Long-term Investment Intensity of 0.2% as of September 2024. Long-term investments of $284.00K represent 0.2% of total assets of $169.38 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Silence Therapeutics PLC (SLN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Silence Therapeutics PLC Long-term Investment Intensity (2020–2023)
This chart shows how Silence Therapeutics PLC's Long-term Investment Intensity has evolved across 4 annual periods from 2020 to 2023. As of September 2024, the intensity stands at 0.2%, reflecting long-term investments of $284.00K against total assets of $169.38 Million USD. Explore Silence Therapeutics PLC (SLN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Silence Therapeutics PLC (2020–2023)
The table below presents the year-by-year Long-term Investment Intensity for Silence Therapeutics PLC from 2020 to 2023, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Silence Therapeutics PLC worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.2% | $284.00K | $119.45 Million | ▼ 0.0 pp |
| 2022 | 0.3% | $284.00K | $107.50 Million | ▼ 0.0 pp |
| 2021 | 0.3% | $301.00K | $96.19 Million | ▼ 0.0 pp |
| 2020 | 0.4% | $303.00K | $85.97 Million | — |